Churchill XII puts Klein back on the SPAC calendar
Klein's Churchill XII lines up a $300 million SPAC IPO
By Erik Aronesty · Published April 11, 2026 · Company page
Churchill XII puts Klein back on the SPAC calendar
NEW YORK, April 11, 2026 - Michael Klein is asking IPO investors to make room for another Churchill vehicle, and the pitch is deliberately familiar: a $300 million trust, a Citi-led book and a sponsor group built around M. Klein and Company.
Churchill Capital Corp XII is seeking to sell 30 million units at $10 each on the Nasdaq Global Market under the proposed unit symbol CXIIU. Each unit carries one Class A ordinary share and one-tenth of one warrant, with whole warrants exercisable at $11.50. The filing also gives Citigroup Global Markets a 45-day option for up to 4.5 million additional units.
The notable part is not that another blank-check company has reached the calendar. It is that Klein is trying to reopen a repeat-issuer channel in a SPAC market that has become far less forgiving since the 2020-2021 boom. The Churchill franchise still gives the deal name recognition, but public investors now tend to separate sponsor pedigree from merger outcomes.
The sponsor economics are clearly laid out. Churchill Sponsor XII LLC, whose managing member is M. Klein Associates and which is affiliated with M. Klein and Company, has subscribed for 350,000 private placement units at $10 apiece, or $3.5 million, in a placement expected to close alongside the IPO. The sponsor also bought founder shares for $25,000. That is useful alignment color, but it is not the same thing as outside institutional demand.
Citi is the sole bookrunner, giving the transaction a cleaner underwriting signal than many smaller SPAC launches. The stated underwriting economics include $4.5 million of cash discount at closing and up to $13.0 million of deferred compensation, with $10.5 million of that deferred amount placed in the trust account.
Churchill XII has not selected a target and says no substantive discussions are under way. The prospectus describes a search for businesses with recurring revenue, stable free-cash-flow potential, acquisition-led growth opportunities and management depth. That language is broad by design. The real underwriting question is whether the Churchill network can source a merger that survives redemptions and public-company scrutiny.
Klein's SPAC record gives both sides of that argument something to cite. Prior Churchill vehicles combined with Clarivate, Skillsoft, MultiPlan, Lucid and, most recently, Infleqtion. Others liquidated or terminated deals, including Churchill V, VI and VII. Churchill IX has announced a combination with Plus Automation, while Churchill XI remains in the search phase after its December 2025 IPO.
The timing is still unfinished. The units are expected to list on or promptly after the prospectus date if Nasdaq approves the application, and the shares and warrants are expected to trade separately on the 52nd day after the prospectus unless Citi allows an earlier split. The SPAC has 24 months after closing to complete a business combination, extendable to 27 months if it has signed a letter of intent, agreement in principle or definitive agreement within the initial window.
For IPOGrid readers, Churchill XII is worth watching because it tests how much premium the market still assigns to repeat SPAC sponsors. A $300 million book is meaningful, but the cleanest read will come later: how quickly the deal prices, how the units trade once listed, and whether Klein can turn another trust into a merger public investors want to keep.